Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jorg Dietrich, M.D.,Ph.D.

Title
Institution
Department
Address
Phone
Fax
Other Positions
Title
Institution
Department

Mentoring
Neuroimaging Markers of Treatment-Associated Neurotoxicity in Glioblastoma Patients Undergoing Brain Radiation and Temozolomide Chemotherapy
Summer, 06/11/12 - 08/03/12

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Brastianos PK, Strickland MR, Lee EQ, Wang N, Cohen JV, Chukwueke U, Forst DA, Eichler A, Overmoyer B, Lin NU, Chen WY, Bardia A, Juric D, Dagogo-Jack I, White MD, Dietrich J, Nayyar N, Kim AE, Alvarez-Breckenridge C, Mahar M, Mora JL, Nahed BV, Jones PS, Shih HA, Gerstner ER, Giobbie-Hurder A, Carter SL, Oh K, Cahill DP, Sullivan RJ. Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis. Nat Commun. 2021 10 12; 12(1):5954. PMID: 34642329.
    Citations:    Fields:    
  2. Karschnia P, Weller J, Blobner J, Stoecklein VM, Dorostkar MM, Rejeski K, Forbrig R, Niyazi M, von Baumgarten L, Dietrich J, Tonn JC, Thon N. Subventricular zone involvement is associated with worse outcome in glioma WHO grade 2 depending on molecular markers. Sci Rep. 2021 Oct 08; 11(1):20045. PMID: 34625590.
    Citations:    Fields:    
  3. Strasser B, Arango NS, Stockmann JP, Gagoski B, Thapa B, Li X, Bogner W, Moser P, Small J, Cahill DP, Batchelor TT, Dietrich J, van der Kouwe A, White J, Adalsteinsson E, Andronesi OC. Improving D-2-hydroxyglutarate MR spectroscopic imaging in mutant isocitrate dehydrogenase glioma patients with multiplexed RF-receive/B0 -shim array coils at 3?T. NMR Biomed. 2021 Oct 05; e4621. PMID: 34609036.
    Citations:    Fields:    
  4. Winter SF, Jo J, Schiff D, Dietrich J. Central Nervous System Complications Among Oncology Patients. Hematol Oncol Clin North Am. 2021 Oct 02. PMID: 34607715.
    Citations:    Fields:    
  5. Gupta M, Burns EJ, Georgantas NZ, Thierauf J, Nayyar N, Gordon A, Jones SS, Pisapia M, Sun Y, Burns RP, Velarde J, Jordan JT, Frigault MJ, Nahed BV, Jones PS, Barker FG, Curry WT, Gupta R, Batchelor TT, Romero JM, Brastianos PK, Marble HD, Martinez-Lage M, Tateishi K, Lennerz JK, Dietrich J, Cahill DP, Carter BS, Shankar GM. A rapid genotyping panel for detection of primary central nervous system lymphoma. Blood. 2021 Aug 05; 138(5):382-386. PMID: 33735913.
    Citations:    Fields:    
  6. Guidon AC, Burton LB, Chwalisz BK, Hillis J, Schaller TH, Amato AA, Betof Warner A, Brastianos PK, Cho TA, Clardy SL, Cohen JV, Dietrich J, Dougan M, Doughty CT, Dubey D, Gelfand JM, Guptill JT, Johnson DB, Juel VC, Kadish R, Kolb N, LeBoeuf NR, Linnoila J, Mammen AL, Martinez-Lage M, Mooradian MJ, Naidoo J, Neilan TG, Reardon DA, Rubin KM, Santomasso BD, Sullivan RJ, Wang N, Woodman K, Zubiri L, Louv WC, Reynolds KL. Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors. J Immunother Cancer. 2021 07; 9(7). PMID: 34281989.
    Citations: 2     Fields:    Translation:Humans
  7. Lim-Fat MJ, Dietrich J. Myelopathies from Neoplasms. Semin Neurol. 2021 Jun; 41(3):291-302. PMID: 34030192.
    Citations:    Fields:    
  8. Karschnia P, Teske N, Thon N, Subklewe M, Tonn JC, Dietrich J, von Baumgarten L. Chimeric Antigen Receptor T Cells for Glioblastoma: Current Concepts, Challenges, and Future Perspectives. Neurology. 2021 08 03; 97(5):218-230. PMID: 33986138.
    Citations:    Fields:    Translation:HumansCells
  9. Winter SF, Klein JP, Vaios EJ, Karschnia P, Lee EQ, Shih HA, Loebel F, Dietrich J. Clinical Presentation and Management of SMART Syndrome. Neurology. 2021 May 04. PMID: 33947781.
    Citations:    Fields:    
  10. Talati P, El-Abtah M, Kim D, Dietrich J, Fu M, Wenke M, He J, Natheir SN, Vangel M, Rapalino O, Vaynrub A, Arrillaga-Romany I, Forst DA, Yen YF, Andronesi O, Kalpathy-Cramer J, Rosen B, Batchelor TT, Gonzalez RG, Gerstner ER, Ratai EM. MR spectroscopic imaging predicts early response to anti-angiogenic therapy in recurrent glioblastoma. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab060. PMID: 34131648.
    Citations:    
  11. Winter SF, Forst DA, Oakley DH, Batchelor TT, Dietrich J. Intracranial Foreign Body Granuloma Mimicking Brain Tumor Recurrence: A Case Series. Oncologist. 2021 05; 26(5):e893-e897. PMID: 33780077.
    Citations: 1     Fields:    Translation:Humans
  12. Dietrich J. The best matrix for the brain: advances in secondary CNS lymphoma. Lancet Haematol. 2021 02; 8(2):e96-e97. PMID: 33513377.
    Citations: 1     Fields:    Translation:Humans
  13. Winter SF, Martinez-Lage M, Clement NF, Hochberg EP, Dietrich J. Fatal neurotoxicity after chimeric antigen receptor T-cell therapy: An unexpected case of fludarabine-associated progressive leukoencephalopathy. Eur J Cancer. 2021 02; 144:178-181. PMID: 33360262.
    Citations:    Fields:    Translation:Humans
  14. Maus MV, Alexander S, Bishop MR, Brudno JN, Callahan C, Davila ML, Diamonte C, Dietrich J, Fitzgerald JC, Frigault MJ, Fry TJ, Holter-Chakrabarty JL, Komanduri KV, Lee DW, Locke FL, Maude SL, McCarthy PL, Mead E, Neelapu SS, Neilan TG, Santomasso BD, Shpall EJ, Teachey DT, Turtle CJ, Whitehead T, Grupp SA. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events. J Immunother Cancer. 2020 12; 8(2). PMID: 33335028.
    Citations: 15     Fields:    Translation:Humans
  15. Winter SF, Vaios EJ, Dietrich J. Central nervous system injury from novel cancer immunotherapies. Curr Opin Neurol. 2020 12; 33(6):723-735. PMID: 32941192.
    Citations: 1     Fields:    Translation:Humans
  16. Gonzalez Castro LN, Dietrich J. Evaluation and management of chimeric antigen receptor (CAR) T-cell-associated neurotoxicity. Neurooncol Pract. 2021 Jun; 8(3):259-265. PMID: 34055373.
    Citations:    
  17. Redjal N, Nahed BV, Dietrich J, Kalkanis SN, Olson JJ. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults. J Neurooncol. 2020 Nov; 150(2):165-213. PMID: 33215343.
    Citations: 2     Fields:    Translation:Humans
  18. Gerstner ER, Emblem KE, Yen YF, Dietrich J, Jordan JT, Catana C, Wenchin KL, Hooker JM, Duda DG, Rosen BR, Kalpathy-Cramer J, Jain RK, Batchelor TT. Vascular dysfunction promotes regional hypoxia after bevacizumab therapy in recurrent glioblastoma patients. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa157. PMID: 33392506.
    Citations: 1     
  19. Karschnia P, Teske N, Dorostkar MM, Siller S, Weller J, Baehring JM, Dietrich J, von Baumgarten L, Herms J, Tonn JC, Thon N. Extent and prognostic value of MGMT promotor methylation in glioma WHO grade II. Sci Rep. 2020 11 12; 10(1):19758. PMID: 33184319.
    Citations: 2     Fields:    Translation:HumansCells
  20. Youssef G, Dietrich J. Ipilimumab: an investigational immunotherapy for glioblastoma. Expert Opin Investig Drugs. 2020 Nov; 29(11):1187-1193. PMID: 32945231.
    Citations: 1     Fields:    Translation:HumansAnimals
  21. Esmaeili M, Stockmann J, Strasser B, Arango N, Thapa B, Wang Z, van der Kouwe A, Dietrich J, Cahill DP, Batchelor TT, White J, Adalsteinsson E, Wald L, Andronesi OC. An integrated RF-receive/B0-shim array coil boosts performance of whole-brain MR spectroscopic imaging at 7 T. Sci Rep. 2020 09 14; 10(1):15029. PMID: 32929121.
    Citations:    Fields:    Translation:Humans
  22. Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, Lin NU, Wang N, Chukwueke U, White MD, Nayyar N, Kim A, Alvarez-Breckenridge C, Krop I, Mahar MK, Bertalan MS, Shaw B, Mora JL, Goss N, Subramanian M, Nayak L, Dietrich J, Forst DA, Nahed BV, Batchelor TT, Shih HA, Gerstner ER, Moy B, Lawrence D, Giobbie-Hurder A, Carter SL, Oh K, Cahill DP, Sullivan RJ. Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med. 2020 Aug; 26(8):1309. PMID: 32555425.
    Citations: 1     Fields:    
  23. Kaulen LD, Karschnia P, Dietrich J, Baehring JM. Autoimmune disease-related primary CNS lymphoma: systematic review and meta-analysis. J Neurooncol. 2020 Aug; 149(1):153-159. PMID: 32683530.
    Citations: 2     Fields:    Translation:Humans
  24. Dietrich J, Versmee L, Drappatz J, Eichler AF, Nayak L, Norden A, Wong E, Pisapia MR, Jones SS, Gordon AB, Chabner BA, Hochberg F, Batchelor TT. Pemetrexed in Recurrent or Progressive Central Nervous System Lymphoma: A Phase I Multicenter Clinical Trial. Oncologist. 2020 09; 25(9):747-e1273. PMID: 32520407.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  25. Winter SF, Vaios EJ, Muzikansky A, Martinez-Lage M, Bussière MR, Shih HA, Loeffler J, Karschnia P, Loebel F, Vajkoczy P, Dietrich J. Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis. Oncologist. 2020 08; 25(8):e1221-e1232. PMID: 32488924.
    Citations: 2     Fields:    Translation:Humans
  26. Sokolov E, Karschnia P, Benjamin R, Hadden RDM, Elwes RCD, Drummond L, Amin D, Paiva V, Pennisi A, Herlopian A, Frigault M, Sanderson R, Inam S, Cole AJ, Dietrich J. Language dysfunction-associated EEG findings in patients with CAR-T related neurotoxicity. BMJ Neurol Open. 2020; 2(1):e000054. PMID: 33681787.
    Citations: 2     
  27. Chi AS, Cahill DP, Reardon DA, Wen PY, Mikkelsen T, Peereboom DM, Wong ET, Gerstner ER, Dietrich J, Plotkin SR, Norden AD, Lee EQ, Nayak L, Tanaka S, Wakimoto H, Lelic N, Koerner MV, Klofas LK, Bertalan MS, Arrillaga-Romany IC, Betensky RA, Curry WT, Borger DR, Balaj L, Kitchen RR, Chakrabortty SK, Valentino MD, Skog J, Breakefield XO, Iafrate AJ, Batchelor TT. Exploring Predictors of Response to Dacomitinib in EGFR-Amplified Recurrent Glioblastoma. JCO Precis Oncol. 2020; 4. PMID: 32923886.
    Citations: 3     
  28. Brastianos PK, Lee EQ, Cohen JV, Tolaney SM, Lin NU, Wang N, Chukwueke U, White MD, Nayyar N, Kim A, Alvarez-Breckenridge C, Krop I, Mahar MK, Bertalan MS, Shaw B, Mora JL, Goss N, Subramanian M, Nayak L, Dietrich J, Forst DA, Nahed BV, Batchelor TT, Shih HA, Gerstner ER, Moy B, Lawrence D, Giobbie-Hurder A, Carter SL, Oh K, Cahill DP, Sullivan RJ. Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis. Nat Med. 2020 08; 26(8):1280-1284. PMID: 32483359.
    Citations: 11     Fields:    Translation:HumansCTClinical Trials
  29. Forst DA, Quain K, Landay SL, Anand M, Kaslow-Zieve E, Mesa MM, Jacobs JM, Dietrich J, Parsons MW, Horick N, Greer JA, Batchelor TT, Jackson VA, El-Jawahri A, Temel JS. Perceptions of prognosis and goal of treatment in patients with malignant gliomas and their caregivers. Neurooncol Pract. 2020 Oct; 7(5):490-497. PMID: 33014389.
    Citations: 1     
  30. Karschnia P, Batchelor TT, Jordan JT, Shaw B, Winter SF, Barbiero FJ, Kaulen LD, Thon N, Tonn JC, Huttner AJ, Fulbright RK, Loeffler J, Dietrich J, Baehring JM. Primary dural lymphomas: Clinical presentation, management, and outcome. Cancer. 2020 06 15; 126(12):2811-2820. PMID: 32176324.
    Citations: 5     Fields:    Translation:Humans
  31. Vaios EJ, Winter SF, Muzikansky A, Nahed BV, Dietrich J. Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma. Neurooncol Adv. 2020 Jan-Dec; 2(1):vdaa031. PMID: 32642690.
    Citations: 1     
  32. Li X, Strasser B, Jafari-Khouzani K, Thapa B, Small J, Cahill DP, Dietrich J, Batchelor TT, Andronesi OC. Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas. Radiology. 2020 03; 294(3):589-597. PMID: 31909698.
    Citations: 1     Fields:    Translation:Humans
  33. McDuff SGR, Dietrich J, Atkins KM, Oh KS, Loeffler JS, Shih HA. Radiation and chemotherapy for high-risk lower grade gliomas: Choosing between temozolomide and PCV. Cancer Med. 2020 01; 9(1):3-11. PMID: 31701682.
    Citations: 4     Fields:    Translation:HumansCells
  34. Gerstner ER, Emblem KE, Chang K, Vakulenko-Lagun B, Yen YF, Beers AL, Dietrich J, Plotkin SR, Catana C, Hooker JM, Duda DG, Rosen B, Kalpathy-Cramer J, Jain RK, Batchelor T. Bevacizumab Reduces Permeability and Concurrent Temozolomide Delivery in a Subset of Patients with Recurrent Glioblastoma. Clin Cancer Res. 2020 01 01; 26(1):206-212. PMID: 31558474.
    Citations: 13     Fields:    Translation:Humans
  35. Abramson JS, Irwin KE, Frigault MJ, Dietrich J, McGree B, Jordan JT, Yee AJ, Chen YB, Raje NS, Barnes JA, Davis B. Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma. Cancer. 2019 Nov 01; 125(21):3692-3698. PMID: 31503324.
    Citations: 7     Fields:    Translation:Humans
  36. Winter SF, Loebel F, Loeffler J, Batchelor TT, Martinez-Lage M, Vajkoczy P, Dietrich J. Treatment-induced brain tissue necrosis: a clinical challenge in neuro-oncology. Neuro Oncol. 2019 09 06; 21(9):1118-1130. PMID: 30828724.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  37. Lee EQ, Muzikansky A, Duda DG, Gaffey S, Dietrich J, Nayak L, Chukwueke UN, Beroukhim R, Doherty L, Laub CK, LaFrankie D, Fontana B, Stefanik J, Ruland S, Caruso V, Bruno J, Ligon K, Reardon DA, Wen PY. Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma. Cancer Med. 2019 10; 8(13):5988-5994. PMID: 31444999.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  38. Frigault MJ, Dietrich J, Martinez-Lage M, Leick M, Choi BD, DeFilipp Z, Chen YB, Abramson J, Crombie J, Armand P, Nayak L, Panzini C, Riley LS, Gallagher K, Maus MV. Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma. Blood. 2019 09 12; 134(11):860-866. PMID: 31320380.
    Citations: 33     Fields:    Translation:HumansCells
  39. Karschnia P, Jordan JT, Forst DA, Arrillaga-Romany IC, Batchelor TT, Baehring JM, Clement NF, Gonzalez Castro LN, Herlopian A, Maus MV, Schwaiblmair MH, Soumerai JD, Takvorian RW, Hochberg EP, Barnes JA, Abramson JS, Frigault MJ, Dietrich J. Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells. Blood. 2019 05 16; 133(20):2212-2221. PMID: 30808634.
    Citations: 43     Fields:    Translation:Humans
  40. Nayyar N, White MD, Gill CM, Lastrapes M, Bertalan M, Kaplan A, D'Andrea MR, Bihun I, Kaneb A, Dietrich J, Ferry JA, Martinez-Lage M, Giobbie-Hurder A, Borger DR, Rodriguez FJ, Frosch MP, Batchelor E, Hoang K, Kuter B, Fortin S, Holdhoff M, Cahill DP, Carter S, Brastianos PK, Batchelor TT. MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas. Blood Adv. 2019 02 12; 3(3):375-383. PMID: 30723112.
    Citations: 12     Fields:    Translation:HumansCells
  41. Karschnia P, Sengupta S, Dietrich J. MRI findings in trigeminal neuropathy: bilateral Meckel's cave lesions. Acta Neurol Belg. 2020 Feb; 120(1):171-173. PMID: 30712245.
    Citations:    Fields:    Translation:Humans
  42. Karschnia P, Parsons MW, Dietrich J. Pharmacologic management of cognitive impairment induced by cancer therapy. Lancet Oncol. 2019 02; 20(2):e92-e102. PMID: 30723041.
    Citations: 11     Fields:    Translation:Humans
  43. Parsons MW, Dietrich J. Assessment and management of cognitive changes in patients with cancer. Cancer. 2019 06 15; 125(12):1958-1962. PMID: 30668896.
    Citations:    Fields:    Translation:Humans
  44. Gonzalez Castro LN, Dietrich J, Forst DA. Stuttering as the first sign of CAR-T-cell-related encephalopathy syndrome (CRES). J Cancer Res Clin Oncol. 2019 Jul; 145(7):1917-1918. PMID: 30539279.
    Citations: 2     Fields:    Translation:HumansCells
  45. Dworkin M, Mehan W, Niemierko A, Kamran SC, Lamba N, Dietrich J, Martinez-Lage M, Oh KS, Batchelor TT, Wen PY, Loeffler JS, Shih HA. Increase of pseudoprogression and other treatment related effects in low-grade glioma patients treated with proton radiation and temozolomide. J Neurooncol. 2019 Mar; 142(1):69-77. PMID: 30488294.
    Citations: 12     Fields:    Translation:Humans
  46. Ly KI, Oakley DH, Pine AB, Frosch MP, Chiou SH, Betensky RA, Pomerantz SR, Hochberg FH, Batchelor TT, Cahill DP, Dietrich J. Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic Study. Oncologist. 2019 03; 24(3):402-413. PMID: 30097523.
    Citations:    Fields:    Translation:Humans
  47. Herlopian A, Dietrich J, Abramson JS, Cole AJ, Westover MB. EEG findings in CAR T-cell therapy-related encephalopathy. Neurology. 2018 07 31; 91(5):227-229. PMID: 29959264.
    Citations: 8     Fields:    Translation:Humans
  48. Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT, Sahay A, Scadden DT. Bone marrow drives central nervous system regeneration after radiation injury. J Clin Invest. 2018 06 01; 128(6):2651. PMID: 29856368.
    Citations: 3     Fields:    
  49. Ahluwalia M, Barnett GH, Deng D, Tatter SB, Laxton AW, Mohammadi AM, Leuthardt E, Chamoun R, Judy K, Asher A, Essig M, Dietrich J, Chiang VL. Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis. J Neurosurg. 2018 05 04; 130(3):804-811. PMID: 29726782.
    Citations: 25     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  50. Andronesi OC, Arrillaga-Romany IC, Ly KI, Bogner W, Ratai EM, Reitz K, Iafrate AJ, Dietrich J, Gerstner ER, Chi AS, Rosen BR, Wen PY, Cahill DP, Batchelor TT. Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate. Nat Commun. 2018 04 16; 9(1):1474. PMID: 29662077.
    Citations: 42     Fields:    Translation:HumansCTClinical Trials
  51. Prust ML, Jafari-Khouzani K, Kalpathy-Cramer J, Polaskova P, Batchelor TT, Gerstner ER, Dietrich J. Standard chemoradiation in combination with VEGF targeted therapy for glioblastoma results in progressive gray and white matter volume loss. Neuro Oncol. 2018 01 22; 20(2):289-291. PMID: 29315410.
    Citations: 2     Fields:    Translation:Humans
  52. Dietrich J, Baryawno N, Nayyar N, Valtis YK, Yang B, Ly I, Besnard A, Severe N, Gustafsson KU, Andronesi OC, Batchelor TT, Sahay A, Scadden DT. Bone marrow drives central nervous system regeneration after radiation injury. J Clin Invest. 2018 01 02; 128(1):281-293. PMID: 29202481.
    Citations: 15     Fields:    Translation:AnimalsCellsPHPublic Health
  53. Klein JP, Dietrich J. Neuroradiologic Pearls for Neuro-oncology. Continuum (Minneap Minn). 2017 12; 23(6, Neuro-oncology):1619-1634. PMID: 29200114.
    Citations:    Fields:    Translation:Humans
  54. Shaw AT, Felip E, Bauer TM, Besse B, Navarro A, Postel-Vinay S, Gainor JF, Johnson M, Dietrich J, James LP, Clancy JS, Chen J, Martini JF, Abbattista A, Solomon BJ. Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial. Lancet Oncol. 2017 12; 18(12):1590-1599. PMID: 29074098.
    Citations: 155     Fields:    Translation:HumansCTClinical Trials
  55. Andronesi OC, Esmaeili M, Borra RJH, Emblem K, Gerstner ER, Pinho MC, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Ivy SP, Wen PY, Duda DG, Jain R, Rosen BR, Sorensen GA, Batchelor TT. Early changes in glioblastoma metabolism measured by MR spectroscopic imaging during combination of anti-angiogenic cediranib and chemoradiation therapy are associated with survival. NPJ Precis Oncol. 2017; 1. PMID: 29202103.
    Citations: 5     
  56. Jordan JT, Miller JJ, Cushing T, Seijo M, Batchelor TT, Arrillaga-Romany IC, Shih HA, Nachtigall LB, Loeffler JS, Dietrich J. Temozolomide therapy for aggressive functioning pituitary adenomas refractory to surgery and radiation: a case series. Neurooncol Pract. 2018 Mar; 5(1):64-68. PMID: 31385986.
    Citations: 3     
  57. Winter SF, Loebel F, Dietrich J. Role of ketogenic metabolic therapy in malignant glioma: A systematic review. Crit Rev Oncol Hematol. 2017 Apr; 112:41-58. PMID: 28325264.
    Citations: 24     Fields:    Translation:HumansAnimals
  58. Roongpiboonsopit D, Kuijf HJ, Charidimou A, Xiong L, Vashkevich A, Martinez-Ramirez S, Shih HA, Gill CM, Viswanathan A, Dietrich J. Evolution of cerebral microbleeds after cranial irradiation in medulloblastoma patients. Neurology. 2017 Feb 21; 88(8):789-796. PMID: 28122904.
    Citations: 11     Fields:    Translation:HumansPHPublic Health
  59. Kalpathy-Cramer J, Chandra V, Da X, Ou Y, Emblem KE, Muzikansky A, Cai X, Douw L, Evans JG, Dietrich J, Chi AS, Wen PY, Stufflebeam S, Rosen B, Duda DG, Jain RK, Batchelor TT, Gerstner ER. Phase II study of tivozanib, an oral VEGFR inhibitor, in patients with recurrent glioblastoma. J Neurooncol. 2017 02; 131(3):603-610. PMID: 27853960.
    Citations: 23     Fields:    Translation:HumansCTClinical Trials
  60. Vaios EJ, Nahed BV, Muzikansky A, Fathi AT, Dietrich J. Bone marrow response as a potential biomarker of outcomes in glioblastoma patients. J Neurosurg. 2017 Jul; 127(1):132-138. PMID: 27739940.
    Citations: 7     Fields:    Translation:Humans
  61. Dietrich J, Prust M. Author Response. Neurology. 2016 Mar 08; 86(10):979. PMID: 27390802.
    Citations:    Fields:    Translation:Humans
  62. Chamberlain MC. Standard chemoradiation for glioblastoma results in progressive brain volume loss. Neurology. 2016 Mar 08; 86(10):979. PMID: 26952303.
    Citations: 1     Fields:    Translation:Humans
  63. LaBuzetta JN, Mordes D, Arrillaga I, Chi A, Dietrich J. A 34-Year-Old Male with An Intracranial Mass. Brain Pathol. 2016 Mar; 26(2):289-90. PMID: 27000488.
    Citations:    Fields:    Translation:Humans
  64. Redjal N, Reinshagen C, Le A, Walcott BP, McDonnell E, Dietrich J, Nahed BV. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide. J Neurooncol. 2016 May; 127(3):505-14. PMID: 26830093.
    Citations: 15     Fields:    Translation:Humans
  65. Belkind-Gerson J, Hotta R, Whalen M, Nayyar N, Nagy N, Cheng L, Zuckerman A, Goldstein AM, Dietrich J. Engraftment of enteric neural progenitor cells into the injured adult brain. BMC Neurosci. 2016 Jan 25; 17:5. PMID: 26810757.
    Citations: 3     Fields:    Translation:AnimalsCellsPHPublic Health
  66. Andronesi OC, Loebel F, Bogner W, Marjanska M, Vander Heiden MG, Iafrate AJ, Dietrich J, Batchelor TT, Gerstner ER, Kaelin WG, Chi AS, Rosen BR, Cahill DP. Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate. Clin Cancer Res. 2016 Apr 01; 22(7):1632-41. PMID: 26534967.
    Citations: 56     Fields:    Translation:Humans
  67. Prust MJ, Jafari-Khouzani K, Kalpathy-Cramer J, Polaskova P, Batchelor TT, Gerstner ER, Dietrich J. Standard chemoradiation for glioblastoma results in progressive brain volume loss. Neurology. 2015 Aug 25; 85(8):683-91. PMID: 26208964.
    Citations: 20     Fields:    Translation:HumansCTClinical Trials
  68. Redjal N, Agarwalla PK, Dietrich J, Dinevski N, Stemmer-Rachamimov A, Nahed BV, Loeffler JS. Remote acute demyelination after focal proton radiation therapy for optic nerve meningioma. J Clin Neurosci. 2015 Aug; 22(8):1367-9. PMID: 25937571.
    Citations: 1     Fields:    Translation:Humans
  69. Belkind-Gerson J, Hotta R, Nagy N, Thomas AR, Graham H, Cheng L, Solorzano J, Nguyen D, Kamionek M, Dietrich J, Cherayil BJ, Goldstein AM. Colitis induces enteric neurogenesis through a 5-HT4-dependent mechanism. Inflamm Bowel Dis. 2015 Apr; 21(4):870-8. PMID: 25742399.
    Citations: 24     Fields:    Translation:AnimalsCells
  70. Etherton MR, Neagu MR, Oakley DH, Koch MJ, Shin JH, Frosch MP, Berkowitz AL, Dietrich J. A 20-year-old man with back pain and lower extremity weakness. JAMA Neurol. 2015 Mar; 72(3):363-6. PMID: 25621865.
    Citations: 1     Fields:    Translation:Humans
  71. Taylor JW, Dietrich J, Gerstner ER, Norden AD, Rinne ML, Cahill DP, Stemmer-Rachamimov A, Wen PY, Betensky RA, Giorgio DH, Snodgrass K, Randall AE, Batchelor TT, Chi AS. Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. J Neurooncol. 2015 Feb; 121(3):557-63. PMID: 25411098.
    Citations: 14     Fields:    Translation:HumansCTClinical Trials
  72. Norden AD, Schiff D, Ahluwalia MS, Lesser GJ, Nayak L, Lee EQ, Rinne ML, Muzikansky A, Dietrich J, Purow B, Doherty LM, LaFrankie DC, Pulverenti JR, Rifenburg JA, Ruland SF, Smith KH, Gaffey SC, McCluskey C, Ligon KL, Reardon DA, Wen PY. Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas. J Neurooncol. 2015 Jan; 121(2):297-302. PMID: 25338318.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  73. Chen YB, Batchelor T, Li S, Hochberg E, Brezina M, Jones S, Del Rio C, Curtis M, Ballen KK, Barnes J, Chi AS, Dietrich J, Driscoll J, Gertsner ER, Hochberg F, LaCasce AS, McAfee SL, Spitzer TR, Nayak L, Armand P. Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma. Cancer. 2015 Jan 15; 121(2):226-33. PMID: 25204639.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  74. Jordan JT, Plotkin S, Dietrich J. Magnetic resonance imaging observations in primary central nervous system lymphoma. JAMA Neurol. 2014 Jul 01; 71(7):918-9. PMID: 24861724.
    Citations: 2     Fields:    Translation:Humans
  75. Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen B, Loeffler JS, Wen PY, Sorensen AG, Jain RK. Increased perfusion due to vascular normalization improves oxygenation and survival in glioblastoma patients treated with cediranib with or without chemoradiation. Neuro Oncol. 2014 Jul; 16 Suppl 3:iii12. PMID: 25165209.
    Citations:    
  76. Batchelor TT, Gerstner ER, Emblem KE, Duda DG, Kalpathy-Cramer J, Snuderl M, Ancukiewicz M, Polaskova P, Pinho MC, Jennings D, Plotkin SR, Chi AS, Eichler AF, Dietrich J, Hochberg FH, Lu-Emerson C, Iafrate AJ, Ivy SP, Rosen BR, Loeffler JS, Wen PY, Sorensen AG, Jain RK. Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation. Proc Natl Acad Sci U S A. 2013 Nov 19; 110(47):19059-64. PMID: 24190997.
    Citations: 157     Fields:    Translation:HumansCTClinical Trials
  77. Lu-Emerson C, Snuderl M, Kirkpatrick ND, Goveia J, Davidson C, Huang Y, Riedemann L, Taylor J, Ivy P, Duda DG, Ancukiewicz M, Plotkin SR, Chi AS, Gerstner ER, Eichler AF, Dietrich J, Stemmer-Rachamimov AO, Batchelor TT, Jain RK. Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma. Neuro Oncol. 2013 Aug; 15(8):1079-87. PMID: 23828240.
    Citations: 88     Fields:    Translation:HumansCells
  78. Arrillaga-Romany IC, Dietrich J. Imaging findings in cancer therapy-associated neurotoxicity. Semin Neurol. 2012 Sep; 32(4):476-86. PMID: 23361490.
    Citations: 5     Fields:    Translation:HumansAnimals
  79. Tanaka S, Louis DN, Curry WT, Batchelor TT, Dietrich J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol. 2013 Jan; 10(1):14-26. PMID: 23183634.
    Citations: 126     Fields:    Translation:HumansCells
  80. Quant E, Dietrich J, Wen PY. Chemotherapy associated nervous system toxicity. Medlink Neurology, www.medlink.com. 2010.
  81. Dietrich J, Diamond EL, Kesari S. Glioma stem cell signaling: therapeutic opportunities and challenges. Expert Rev Anticancer Ther. 2010 May; 10(5):709-22. PMID: 20470003.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  82. Dietrich J. Chemotherapy associated central nervous system damage. Adv Exp Med Biol. 2010; 678:77-85. PMID: 20738009.
    Citations: 17     Fields:    Translation:HumansCells
  83. Dietrich J. Chemotherapy associated central nervous system damage. Advances in Experimental Biology. 2010; in press.
  84. Dietrich J, Han R, Noble M, Yang M. Tamoxifen impairs neural progenitor cell function . Society for Neuro-Oncology, Annual Meeting, Montreal. 2010.
  85. Dietrich J, Hyrien O, Noble M. Quantitative analysis of the effects of chemotherapy on glial precursor cells. . Cancer Research. 2010; in press.
  86. Yang YM, Han R, Dietrich J, Noble M. CNS progenitor cells and oligodendrocytes are vulnerable to tamoxifen. Cancer Research. 2010; in press.
  87. Dietrich J, Diamond E, Kesari S. Glioma stem cell signaling: therapeutic opportunities and challenges. Expert Review Anticancer Therapy. 2010; 10(5):709-722.
  88. Dietrich J. Chemotherapy Associated Central Nervous System Damage. Chemobrain (Robert Raffa, ed). 2010.
  89. Dietrich J, D Wang, T Batchelor. Cediranib (Recentin™) – Profile of a novel anti-angiogenic agent in patients with malignant glioma. Expert Opinion on Investigational Drugs. 2009; 18(10):1-9.
  90. Dietrich J and Wen PY. Chemotherapy associated nervous system toxicity. Medlink Neurology. 2009; www.medlink.com.
  91. Dietrich J and Proschel C. Role of astrocyte biology in white matter disease. Leukodystrophies (Moser, Naidu, Raymond & Eichler, eds.). 2009.
  92. Dietrich J and Kesari S. Effect of cancer treatment on neural stem and progenitor cells. Cancer Treat Res. 2009; 150:81-95.
  93. Dietrich J, Kesari S. Effect of cancer treatment on neural stem and progenitor cells. Cancer Treat Res. 2009; 150:81-95. PMID: 19834663.
    Citations: 1     Fields:    Translation:HumansAnimalsCellsPHPublic Health
  94. Dietrich J, Norden AD, Wen PY. Emerging antiangiogenic treatments for gliomas - efficacy and safety issues. Curr Opin Neurol. 2008 Dec; 21(6):736-44. PMID: 19060566.
    Citations: 23     Fields:    Translation:Humans
  95. Dietrich J, Monje M, Wefel J, Meyers C. Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist. 2008 Dec; 13(12):1285-95. PMID: 19019972.
    Citations: 91     Fields:    Translation:HumansCells
  96. Dietrich J, Monje M, Wefel J, Meyers CM. Clinical Patterns and Biological Correlates of Cognitive Dysfunction Associated with Cancer Therapy. The Oncologist. 2008; 13(12):1-13.
  97. Dietrich J, Imitola J, Kesari S. Mechanisms of Disease: the role of stem cells in the biology and treatment of gliomas. Nat Clin Pract Oncol. 2008 Jul; 5(7):393-404. PMID: 18521117.
    Citations: 15     Fields:    Translation:HumansCells
  98. Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system. J Biol. 2008; 7(4):12. PMID: 18430259.
    Citations: 87     Fields:    Translation:HumansAnimalsCells
  99. Han R, Yang YM, Dietrich J, Luebke A, Mayer-Pröschel M, and Noble M. Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the CNS. Journal of Biology. 2008; 7(4):12-24.
  100. Dietrich J, Norden A, Wen PY. Emerging anti-angiogenic treatments for gliomas: Efficacy and safety issues . Current Opinion in Neurology. 2008; 21(6):736-748.
  101. Dietrich J. Late Effects of Treatment for Brain Tumors. Effect of Cancer Treatment on Neural Stem Cells (Christopher Turner and Stewart Goldman - Editors). 2008.
  102. Dietrich J, and P Wen. Neurologic complications of chemotherapy. Cancer Neurology in Clinical Practice. (David Schiff, Patrick Wen, and Santosh Kesari - Editors). 2008.
  103. Dietrich J and Wen PY. Neurologic complications of chemotherapy. Cancer Neurology in Clinical Practice. (Schiff, Wen, Kesari - Editors). 2008.
  104. Dietrich J, Imitola J., and Kesari S. Mechanisms of Disease: Neural Stem Cells and Gliomas. Nature Clinical Practice Oncology. 2008; 5(7):393-404.
  105. Dietrich J and Wen P. Neurological complications of chemotherapy. MedLink Neurology. 2008; www.medlink.com.
  106. Dietrich J. Effect of Cancer Treatment on Neural Stem Cells. Late Effects of Treatment for Brain Tumors (C Turner and S Goldman - Editors). 2008.
  107. Valaikiene J, Schuierer G, Ziemus B, Dietrich J, Bogdahn U, Schlachetzki F. Transcranial color-coded duplex sonography for detection of distal internal carotid artery stenosis. AJNR Am J Neuroradiol. 2008 Feb; 29(2):347-53. PMID: 18024581.
    Citations: 5     Fields:    Translation:Humans
  108. J Dietrich, Ruolan Han, Miranda Yang, and Mark Noble. Neural Progenitor Cells and Oligodendrocytes Are Highly Sensitive to Chemotherapy. Neurology 68(12). 2007; 68(12):289-290.
  109. Dietrich J, Chow MY, Phelan J, Nigwekar SU. Metastatic primary peritoneal carcinoma presenting as tension hydrothorax. Lancet Oncol. 2006 Sep; 7(9):784. PMID: 16945776.
    Citations:    Fields:    Translation:Humans
  110. Dietrich J and Kempermann G. Role of endogenous neural stem cells in brain function, neurological disease, and brain repair. Brain Repair (Mathias Bahr, Editor). 2006; 191-220.
  111. Dietrich J, R Han, Y Yang, M Mayer-Pröschel, and M Noble. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. Journal of Biology. 2006; 5(22).
  112. DJ Mock, P Chugh, B Kim, C Pröschel, J Dietrich, F Strathmann, B M Blumberg, and M Mayer-Pröschel. Characterization of specific HHV-6 and cell cycle genes implicated in virus-mediated G1/S cell-cycle arrest of glial precursors. Retrovirology 3(1). 2006; 3(1):22-23.
  113. Dietrich J, Chow MY, Phelan J, Nigwekar SU. Metastatic primary peritoneal carcinoma presenting as tension hydrothorax. Lancet Oncology. 2006; 7(9):784.
  114. Dietrich J, Kempermann G. Role of endogenous neural stem cells in neurological disease and brain repair. Adv Exp Med Biol. 2006; 557:191-220. PMID: 16955712.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  115. Dietrich J, Han R, Yang Y, Mayer-Pröschel M, Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol. 2006; 5(7):22. PMID: 17125495.
    Citations: 162     Fields:    Translation:HumansAnimalsCells
  116. Dietrich J and Kempermann G. Role of endogenous neural stem cells in brain function, neurological disease, and brain repair. Advances in Exp Medicine and Biology. 2006; 557:191-204.
  117. Dietrich J, Lacagnina M, Gass D, Richfield E, Mayer-Pröschel M, Noble M, Torres C, Pröschel C. EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med. 2005 Mar; 11(3):277-83. PMID: 15723074.
    Citations: 44     Fields:    Translation:HumansCells
  118. Dietrich J, Noble M and Mayer-Proschel M. Human glial restricted precursor cells - isolation and propagation. 2005.
  119. Noble M and Dietrich J . Brain Tumors (Francis Ali-Osman, Editor). Analysis of neural precursor cells in the context of origin of brain tumors, their treatment, and repair of treatment-associated damage. 2005; 107-124.
  120. Dietrich J, M Lacagnina, D Gass, E Richfield, M Mayer-Pröschel, M Noble, C Torres, and C Pröschel. EIF2B5 mutations compromise generation of GFAP+ astrocytes from neural precursors in Vanishing White Matter leukodystrophy. Nature Medicine. 2005; 11(3):277-283.
  121. Dietrich J and Noble M. Caspase Inhibitors as Anticancer Agents. 2004.
  122. Dietrich J, Blumberg BM, Roshal M, Baker JV, Hurley SD, Mayer-Pröschel M, Mock DJ. Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties. J Neurosci. 2004 May 19; 24(20):4875-83. PMID: 15152048.
    Citations: 24     Fields:    Translation:HumansCells
  123. Hau P, Fabel K, Baumgart U, Rümmele P, Grauer O, Bock A, Dietmaier C, Dietmaier W, Dietrich J, Dudel C, Hübner F, Jauch T, Drechsel E, Kleiter I, Wismeth C, Zellner A, Brawanski A, Steinbrecher A, Marienhagen J, Bogdahn U. Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer. 2004 Mar 15; 100(6):1199-207. PMID: 15022287.
    Citations: 53     Fields:    Translation:HumansCTClinical Trials
  124. Noble M, Dietrich J. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends Neurosci. 2004 Mar; 27(3):148-54. PMID: 15036880.
    Citations: 8     Fields:    Translation:HumansAnimals
  125. Maragakis NJ, Dietrich J, Wong V, Xue H, Mayer-Proschel M, Rao MS, Rothstein JD. Glutamate transporter expression and function in human glial progenitors. Glia. 2004 Jan 15; 45(2):133-43. PMID: 14730707.
    Citations: 33     Fields:    Translation:HumansAnimalsCells
  126. Hau P, Fabel K, Baumgart U, Ruemmele P, Grauer O, Bock A, Dietmaier W, Dietrich J et al. Pegylated Liposomal Doxorubicine – Efficacy in Patients with Recurrent High-Grade Glioma. Cancer. 2004; 15(6):1199-1207.
  127. J. Dietrich, B. M. Blumberg, M. Roshal, J. V. Baker, S. D.Hurley, M. Mayer-Pröschel, and D. J. Mock. Human Herpesvirus 6 increases oligodendrocyte differentiation from oligodendrocyte progenitor cells. Journal of Neuro-Virology 10. 2004; 10.
  128. Noble M and Dietrich J. The complex identity of brain tumors: emerging concerns regarding origin, diversity and plasticity. Trends in Neuroscience. 2004; 27(3):101-107.
  129. Dietrich J, BM Blumberg, M Roshal, JV Baker, SD Hurley, M Mayer-Pröschel and DJ Mock. Infection with an Endemic Human Herpesvirus Disrupts Critical Glial Precursor Cell Properties. Journal of Neuroscience. 2004; 24(20):4875-4883.
  130. Dietrich J, J Marienhagen, B Schalke, U Bogdahn and F Schlachetzki. Neurovascular toxicity following chemotherapy with cisplatin, etoposide and ifosfamide. Annals of Pharmacotherapy. 2004; 38:242-246.
  131. Dietrich J, J Marienhagen, B Schalke, U Bogdahn and F Schlachetzki. Neurovascular toxicity following chemotherapy with cisplatin, etoposide and ifosfamide. Annals of Pharmacotherapy. 2004; 38:242-246.
  132. AH Moore, M Noble, MK O’Banion and J Dietrich. Evaluation of cell proliferation, apoptosis and gliosis following neonatal brain irradiation. Proceedings of the Society for Neuroscience. 2004; 30:940.12.
  133. J Dietrich, BM Blumberg, M Roshal, JV Baker, SD Hurley, M Mayer-Pröschel and DJ Mock . Infection of human glial precursor cells induces G1/S cell-cycle arrest and alteration of critical cell functions related to activation of DNA damage mechanisms. . Journal of Neurovirology. 2004.
  134. Maragakis NJ, J Dietrich, V Wong, H Xue, M Mayer-Proschel, MS Rao, JD Rothstein. Glutamate transporter expression in human glial progenitors. Glia. 2004; 45(2):133-143.
  135. Dietrich J, Marienhagen J, Schalke B, Bogdahn U, Schlachetzki F. Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide. Ann Pharmacother. 2004 Feb; 38(2):242-6. PMID: 14742759.
    Citations: 7     Fields:    Translation:Humans
  136. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer O, Wismeth C, Klinkhammer-Schalke M, Allgäuer M, Schuierer G, Koch H, Schlaier J, Ulrich W, Brawanski A, Bogdahn U, Steinbrecher A. Salvage therapy in patients with glioblastoma: is there any benefit? Cancer. 2003 Dec 15; 98(12):2678-86. PMID: 14669289.
    Citations: 28     Fields:    Translation:Humans
  137. C Pröschel, J Dietrich, M Lacagninga, D Gass, E Richfield, M Noble, M Mayer-Pröschel. Analysis of glial lineage cells derived from a CACH/VWM leukodystrophy patient. Proceedings of the Society for Neuroscience 29. 2003; 29.
  138. J Dietrich, BM Blumberg, M Roshal, JV Baker, SD Hurley, M Mayer-Pröschel, and DJ Mock . Human Herpesvirus 6 Impairs Division and Alters Differentiation of Human Glial Precursors. Journal of Neuro-Virology 9(3). 2003; 9(3):33.
  139. J Dietrich and M Noble. Long-term impairment of cell proliferation and increased cell death in the adult CNS after chemotherapy. Proceedings of the American Association for Cancer Research (AACR). 2003; 44.
  140. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J et al. Salvage Therapy in Patients with Glioblastoma - is there any benefit?. Cancer. 2003; 98(12):2678-2686.
  141. J Dietrich, JV Baker, SD Hurley, B Blumberg, M Mayer-Proschel and DJ Mock . Effects of human herpesvirus type 6 (HHV-6) on cell proliferation and differentiation in human glial precursor cells. Proceedings of the Society for Neuroscience 29. 2003; 29.
  142. Dietrich J, Noble M, Mayer-Proschel M. Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia. 2002 Oct; 40(1):65-77. PMID: 12237844.
    Citations: 37     Fields:    Translation:HumansCells
  143. Dietrich J, Easterday MC. Developing concepts in neural stem cells. Trends Neurosci. 2002 Mar; 25(3):129-31. PMID: 11852138.
    Citations: 1     Fields:    Translation:HumansAnimalsCells
  144. Noble M, Dietrich J. Intersections between neurobiology and oncology: tumor origin, treatment and repair of treatment-associated damage. Trends Neurosci. 2002 Feb; 25(2):103-7. PMID: 11814563.
    Citations: 2     Fields:    Translation:HumansAnimalsCells
  145. Dietrich J, M Noble and M Mayer-Proschel . Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia. 2002; 40(1):65-77.
  146. P Hau, J Dietrich, K Fabel, U Baumgart, O Grauer et al. Liposomal doxorubicin with and without tamoxifen in the salvage treatment of high grade glioma – a phase II study. Proceedings of the American Society of Clinical Oncology (ASCO) 38. 2002; 38:312.
  147. Dietrich J and MC Easterday. Developing Concepts in Neural Stem Cells. Trends in Neuroscience. 2002; 25(3):129-131.
  148. P Hau, J Dietrich, K Fabel and U Bogdahn. Advances in the therapy of high-grade glioma at relapse: pegylated liposomal doxorubicin. Expert Reviews in Neurotherapeutics. 2002; 2(5):89-96.
  149. NJ Maragakis, V Wong, H Xue, MS Rao, J Dietrich, M Mayer-Proschel, JD Rothstein. Glutamate transporter expression and function in human glial progenitors. Proceedings of the Society for Neuroscience 28. 2002; 28:424.9.
  150. J Dietrich, M Noble and M Mayer-Proschel. In vitro characterization of human glial restricted precursor cells. Faseb Journal 16(5). 2002; 16(5):1112.
  151. M Noble and J Dietrich. Intersections between neurobiology and oncology: tumor origin, tumor treatment and repair of treatment associated damage. Trends in Neuroscience. 2002; 25(2):103-107.
  152. Fabel K, Dietrich J, Hau P, Wismeth C, Winner B, Przywara S, Steinbrecher A, Ullrich W, Bogdahn U. Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin. Cancer. 2001 Oct 01; 92(7):1936-42. PMID: 11745268.
    Citations: 36     Fields:    Translation:HumansCTClinical Trials
  153. K Fabel, J Dietrich, P Hau et al. Recurrent High-Grade Glioma: Stabilization After Treatment with Pegylated Doxorubicin in Combination with Tamoxifen – a phase II clinical trial. Proceedings of the American Society of Clinical Oncology (ASCO) 37. 2001; 37:2049.
  154. Dietrich J, Hau P, Fabel K, Baumgart U, Jauch T, Moriabadi N, Zellner A, Steinbrecher A, Bogdahn U . Phase-II Studie bei hochmalignen Gliomen: Stabilisierung unter Therapie mit liposomal verkapseltem Doxorubicin. Aktuelle Neurologie 35. 2001; 35:211.
  155. J Dietrich, Hau P, Fabel K, Zellner A, Steinbrecher A, Ullrich W, and Bogdahn U. Phase II Clinical Trial in High-Grade Glioma: Stabilization of Disease in Patients treated with Liposomal Doxorubicin. Proceedings of the American Society of Clinical Oncology (ASCO) 37. 2001; 37:262.
  156. J Dietrich, DJ Messina, PA Tresco, M Noble, M Mayer-Proschel. Characterization of human glia restricted precursor (hGRP) cells in vitro and after transplantation into the adult mammalian brain. Proceedings of the Society for Neuroscience 27. 2001; 27(2):37.
  157. J Dietrich, M Mayer-Proeschel, M Noble. Chemosensitivity of Glia and Glia Precursor Cells. Proceedings of the American Association for Cancer Research (AACR) 42. 2001; 42:553-554.
  158. Fabel K, Hau P, Dietrich J, Baumgart U, Jauch T, Moriabadi N, Zellner A, Steinbrecher A, Bogdahn U. 13-cis-Retinsaeure in der Erhaltungstherapie bei makroskopisch tumorfreien Patienten mit hochmalignem Gliom nach Abschluss der Primaertherapie. Aktuelle Neurologie 35. 2001; 35:121.
  159. Aigner L, Fluegel D, Dietrich J, Ploetz S, Winkler J. Isolated lissencephaly sequence and double-cortex syndrome in a German family with a novel doublecortin mutation. Neuropediatrics. 2000 Aug; 31(4):195-8. PMID: 11071144.
    Citations: 5     Fields:    Translation:HumansCells
  160. K Fabel-Schulte, P Hau, J Dietrich, C Wismeth, M Angerer, A Steinbrecher, R Apfel, A Brawanski, U Bogdahn. 13-cis-retinoic acid as a potential treatment in glioma patients who show stable disesase after combined modality treatment. Proceedings of the American Society of Clinical Oncology (ASCO) 36. 2000; 36:662.
  161. J Dietrich, P Hau, K Fabel-Schulte, C Wismeth, M Angerer, A Steinbrecher, W Ulrich, A Brawanski, U Bogdahn. Liposomal doxorubicin (Caelyx‚) in the treatment of recurrent high-grade glioma – a phase I/II study. Proceedings of the American Society of Clinical Oncology (ASCO) 36. 2000; 36:661.
  162. Fabel-Schulte K, Dietrich J, Hau P, Wismeth C, Angerer M, Bogdahn U. Phase I/II pilot study of liposomal doxorubicin (Caelyx‚) in the treatment of recurrent high-grade gliomas. Proceedings of the American Association for Cancer Research (AACR) 41. 2000; 41:1644.
  163. Dietrich J und Bogdahn U. Standard therapy and novel treatment concepts of malignant gliomas. Onkologie. 1999; 3-7.
  164. Dietrich J, Angerer M, Bodenteich A, Ullrich H, Schlachetzki F, Bogdahn U, Drlicek M . Paraneoplastic cerebellar degeneration with severe ataxia in a patient with anti-Yo antibodies: clinical presentation and treatment. Neuropsychiatrie. 1999; 13(1):2.
  165. P Hau, J Dietrich, U Bogdahn. Therapy of malignant gliomas. Onkologie. 1999; 11:34-35.
  166. Dietrich J, Aigner L, Flügel D, Plötz S, Winkler J. A novel mutation in the doublecortin gene in a family with Doublecortex syndrome and Lissencephaly. Aktuelle Neurologie 26. 1999; 26(1):77-78.
  167. Dietrich J, Sachsenheimer W, Kempermann G, Bach A, Bogdahn U. Decreased expression of VEGF receptor flt-1 in malignant gliomas — semiquantitative analysis of flt-1 mRNA expression in brain tumors using Lamin B as internal standard. Proceedings of the American Association for Cancer Research (AACR) 40. 1999; 40:1512.
  168. C Framme, J Dietrich, CP Lohmann, HG Sachs. Eye involvement in circumscript cutaneous sclerosis - a manifestation of borreliosis?. Klinisches Monatsblatt fur Augenheilkunde. 1999; 215:258-262.
  169. Dietrich J, Angerer M, Bodenteich A, Ullrich H, Schlachetzki F, Bogdahn U, Drlicek M. Paraneoplastic cerebellar degeneration with severe ataxia in a patient with anti-Yo antibodies: clinical presentation and treatment. Neuropsychiatrie 13. 1999; 13(1):2.
  170. Dietrich J. Expression analysis of the neurotransmitter receptors for dopamine and serotonin, and of the growth factor receptors for Endothelin A, Endothelin B, and VEGF in Human Brain Tumors and Normal Human Brain. 1998.
  171. J Dietrich, G Kempermann, W Sachsenheimer, A Bach, K Fabel-Schulte, U Bogdahn. Expression of endothelin receptors in brain tumors. Journal of Neuro-Oncology 39. 1998; 39(2):269.
  172. F Schlachetzki, T Hoelscher, B Götz, J Dietrich, U Bogdahn. Three dimensional transcranial color-coded duplex sonography - a new perspective?. Aktuelle Neurologie 25. 1998; 25:150.
  173. Dietrich J, Kempermann G, Sachsenheimer W, Bach A, Bogdahn U. Semiquantitative analysis of dopamine receptor expression in human brain tumors. Proceedings of the American Association for Cancer Research (AACR) 39. 1998; 39:2409.
  174. J Dietrich, I Trender, F Schlachetzki, M Angerer, U Bogdahn. Stiff-Person-Like Syndrome in Addison’s Disease. Movement Disorders 13. 1998; 13(2):207.
  175. J Dietrich, I Trender, F Schlachetzki, M Angerer, U Bogdahn . Stiff-Person-Like Syndrome in Addison’s Disease. Movement Disorders. 1998; 13(2):207.
  176. F Schlachetzki, T Hoelscher, J Dietrich, U Bogdahn . Persistent trigeminal artery associated with occlusion of the left internal carotid artery. Annals of Neurology 44. 1998; 44(3):113.
  177. F Schlachetzki, T Hoelscher, J Dietrich, U Bogdahn . Persistent trigeminal artery associated with occlusion of the left internal carotid artery. Annals of Neurology. 1998; 44(3):113.
  178. J Dietrich, G Kempermann, HG Kuhn, W Sachsenheimer, A Bach, U Bogdahn. Semiquantitative analysis of VEGF receptor expression in gliomas and normal cortex. Proceedings of the Society for Neuroscience 23. 1997; 23(2445).
  179. Gaiger A, Lion T, Födinger M, Dietrich J, Wolz M, Sillaber C, Henn T, Korninger L, Schwarzinger I, Mitterbauer G, Kyrle P A, Lechner K. Cytogenetic and moleculargenetic analyses in a patient with M-BCR rearranged Philadelphia positive AML. Annals of Hematology 67. 1993; 67:36.
  180. Gaiger A, T Lion, P Kahls, T Henn, J Dietrich, H Greinix, K Feil, K Geissler, K Lechner . Moleculargenetic analyses in patients with chronic myeloid leukemia: Increase of specific mRNA expression during progression to blast crisis. Annals of Hematology 67. 1993; 67:36.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Dietrich's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (364)
Explore
_
Co-Authors (139)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.